20 results found.

Brain and Central Nervous System Tumors, Intraocular Melanoma, Lu Clinical Trial using DNA analysis; immunologic technique; pharmacological study; iodine I 131 monoclonal antibody 3F8; 131I-3F8

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms.
DNA analysis; immunologic technique; pharmacological study; iodine I 131 monoclonal antibody 3F8; 131I-3F8

Neoplasms,, Metastatic Cancer,, Non-Small Cell Lung Cancer, or Ad Clinical Trial using AZD6244; Docetaxel

AstraZeneca - Recruiting 20 years or older.
- A Phase I, Open-Label Study to Investigate the Safety and Tolerability of AZD6244 (Selumetinib) When Given as a Monotherapy in Japanese Patients With Advanced Solid Malignancies, and When Given in Combination With Docetaxel as 2nd Line Therapy in Japanese Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB-IV).
AZD6244; Docetaxel

Small Cell Lung Carcinoma, or Malignant Epithelial Neoplasms Clinical Trial using (Belinostat) (PDX101); Cisplatin; Etoposide

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With a Focus on Small Cell Lung Cancer and Other Cancers of Neuroendocrine Origin.
(Belinostat) (PDX101); Cisplatin; Etoposide

Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasm Clinical Trial using 5-Fluoro-2-Deoxycytidine (FdCyd); Tetrahydrouridine (THU)

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU).
5-Fluoro-2-Deoxycytidine (FdCyd); Tetrahydrouridine (THU)

Lung or Prostatic Neoplasms, Colorectal or Kidney Neoplasms, Panc Clinical Trial using NK cells +CliniMACs CD3 and CD56 systems

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 70 years.
- Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK TRAIL Cytotoxicity With Bortezomib.
NK cells +CliniMACs CD3 and CD56 systems

Lung Neoplasms, Liver Neoplasms, Kidney Neoplasms, or Cancer Clinical Trial using Laser-Assisted Angle Selection System; Block-Assisted Angle Selection System

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy.
Laser-Assisted Angle Selection System; Block-Assisted Angle Selection System

Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasm Clinical Trial using Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine.
Tetrahydrouridine (THU); [F-18]-5-FLUORO-2'-DEOXYCYTIDINE

Lung Neoplasms Clinical Trial using Radiation Concurrent Chemotherapy

Proton Collaborative Group - Recruiting 18 years or older.
- A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer.
Radiation Concurrent Chemotherapy

Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms, or Clinical Trial using Tumor biopsy; Phlebotomy

Stanford University - Recruiting 18 years or older.
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers.
Tumor biopsy; Phlebotomy

Lung Neoplasms Clinical Trial

Chinese Alliance Against Lung Cancer - Recruiting 40 years to 75 years.
- Multicenter Study for Risk Stratification of Patients Presenting With Symptoms Related to Lung Cancer Using the Lung Cancer Biomarker Panel (LCBP) in China.

Lung Cancer, Esophageal Cancer, Mesothelioma, Gastrointestinal Ne Clinical Trial using Mithramycin

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase II Evaluation of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum.
Mithramycin

Neoplasms, Neoplasm Metastasis, Melanoma, Carcinoma, Non-Small-Ce Clinical Trial using LY3009120 capsule

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer.
LY3009120 capsule

Lung and Pleural Malignancies, Neoplasms, or Nodules Clinical Trial using EC17

University of Pennsylvania - Recruiting 18 years or older.
- Pilot and Feasibility Study of the Imaging Potential of EC17.
EC17

Lung Neoplasms Clinical Trial using Sublobar Resection; Stereotactic Body Radiotherapy (SBRT)

Mayo Clinic - Recruiting 18 years or older.
- Randomized Phase II Trial of Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients With Early Stage Non-Small Lung Cancer (NSCLC).
Sublobar Resection; Stereotactic Body Radiotherapy (SBRT)

Lung Neoplasms Clinical Trial

Sheba Medical Center - Recruiting N/A or older.
- .

Mediastinal Lymphadenopathy, Hilar Lymphadenopathy, Lymphoma, Lun Clinical Trial using EBUS-TBNA

Azienda Ospedaliero, Universitaria Ospedali Riuniti - Recruiting 18 years or older.
- Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration, Using Rapid On-site Cytological Evaluation, for the Diagnosis of Hilar/Mediastinal Enlarged Lymph Nodes: a Randomized Controlled Trial..
EBUS-TBNA

Thoracic Neoplasms, or Non-small Cell Lung Cancer Clinical Trial using 3D conform radiotherapy

Chinese Academy of Medical Sciences - Recruiting 18 years to 70 years.
- Phase III Comparison of Postoperative 3D Conform Radiotherapy After Chemotherapy and Chemotherapy Alone in Patients With Completely Resected Stage IIIA(N2) Non-small Cell Lung Cancer.
3D conform radiotherapy

Carcinoma, Non-Small-Cell Lung, or Head and Neck Neoplasms Clinical Trial using [18F]-ML-10 in conjunction with PET imaging

Aposense Ltd. - Recruiting 18 years or older.
- A Prospective, Multicenter Study, to Evaluate the Efficacy and Safety of [18F]-ML-10, a Positron Emission Tomography (PET) Imaging Radiotracer, in Early Detection of Response of Non-Hematological Tumors to Concurrent Chemoradiotherapy.
[18F]-ML-10 in conjunction with PET imaging

Lung Neoplasms Clinical Trial using gemcitabine, carboplatin; surgery

Hospital Authority, Hong Kong - Recruiting 18 years to 75 years.
- Phase II Study of the Response Rate of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small Cell Lung Cancer Before Surgery.
gemcitabine, carboplatin; surgery

Lung Neoplasms Clinical Trial

National Taiwan University Hospital - Recruiting 20 years or older.
- .